https://www.mlive.com/public-interest/2023/07/promising-alzheimers-therapy-could-soon-get-fda-approval.html
0
0
27 words
0
Comments
In clinical trials, bi-monthly injections of lecanemab slowed deterioration in patients with signs of dementia.
You are the first to view
Create an account or login to join the discussion